UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 314

Sortiert nach

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

The Journal of urology, 2008-07, Vol.180 (1), p.47-54

2008

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapy for Overactive Bladder: Who Approves?

European urology, 2018-10, Vol.74 (4), p.510-511

Staskin, David R.

2018

Link zum Volltext

Verfügbarkeit prüfen

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

The American journal of medicine, 2006-03, Vol.119 (3), p.9-15

2006

Link zum Volltext

Verfügbarkeit prüfen

Bladder Pain Syndrome - an Evolution

2nd ed. 2018 edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence

The Journal of urology, 2010-05, Vol.183 (5), p.1906-1914

2010

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

The Journal of urology, 2019-05, Vol.201 (5), p.967-972

2019

Link zum Volltext

Verfügbarkeit prüfen

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Value in health, 2010-03, Vol.13 (2), p.251-257

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of urology, 2009-04, Vol.181 (4), p.1764-1772

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology (Ridgewood, N.J.), 2010, Vol.75 (1), p.62-68

2010

Link zum Volltext

Verfügbarkeit prüfen

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

The Journal of urology, 2005-08, Vol.174 (2), p.604-607

2005

Link zum Volltext

Verfügbarkeit prüfen

Conflict of interest - who benefits?

Neurourology and urodynamics, 2012-11, Vol.31 (8), p.1221-1222

Staskin, David R.

2012

Link zum Volltext

Verfügbarkeit prüfen

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Expert opinion on pharmacotherapy, 2009-12, Vol.10 (18), p.3103-3111

2009

Link zum Volltext

Verfügbarkeit prüfen

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Urology (Ridgewood, N.J.), 2008-03, Vol.71 (3), p.449-454

2008

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Urology (Ridgewood, N.J.), 2010-05, Vol.75 (5), p.1144-1148

2010

Link zum Volltext

Verfügbarkeit prüfen

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

BJU international, 2011-02, Vol.107 (4), p.612-620

2011

Link zum Volltext

Verfügbarkeit prüfen

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Link zum Volltext

Verfügbarkeit prüfen

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

Urologic clinics of North America, 2006-11, Vol.33 (4), p.465-473

Staskin, David R.

2006

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

The Journal of urology, 2012-05, Vol.187 (5), p.1721-1726

2012

Link zum Volltext

Verfügbarkeit prüfen

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

BJU international, 2006-06, Vol.97 (6), p.1256-1261

2006

Link zum Volltext

Verfügbarkeit prüfen

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Link zum Volltext

Verfügbarkeit prüfen

Advances in female stress urinary incontinence: mid‐urethral slings

BJU international, 2006-09, Vol.98 (s1), p.32-40

2006

Link zum Volltext

Verfügbarkeit prüfen

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?

The Journal of urology, 2009-12, Vol.182 (6), p.2981-2982

2009

Link zum Volltext

Verfügbarkeit prüfen

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

The Journal of urology, 2009-12, Vol.182 (6), p.2981-2982

2009

Link zum Volltext

Verfügbarkeit prüfen

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Neurourology and urodynamics, 2011-09, Vol.30 (7), p.1214-1219

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 314

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Englisch
(314)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Humans
(82)
Life Sciences & Biomedicine
(79)
Science & Technology
(79)
Urology & Nephrology
(62)
Female
(52)
Urology
(40)
Male
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Urology & Urogenital Medicine
(35)
Nephrology. Urinary Tract Diseases
(28)
Middle Aged
(26)
Urinary System Involvement In Other Diseases. Miscellaneous
(26)
Urinary Tract. Prostate Gland
(26)
Urinary Incontinence
(25)
Aged
(22)
Adult
(20)
Treatment Outcome
(20)
Muscarinic Antagonists - Therapeutic Use
(19)
Urinary Bladder, Overactive - Drug Therapy
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

Combination Therapy for Overactive Bladder: Who Approves?

Using Anticholinergics to Treat Overactive Bladder: The Issue of Treatment Tolerability

Bladder Pain Syndrome - an Evolution

Update of AUA Guideline on the Surgical Management of Female Stress Urinary Incontinence

Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

Conflict of interest - who benefits?

Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Trospium Chloride: Distinct Among Other Anticholinergic Agents Available for the Treatment of Overactive Bladder

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

Advances in female stress urinary incontinence: mid‐urethral slings

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Aktive Filter

Suchergebnisse filtern